TOX and metabolic syndrome: It is stated by Cox et al. in a published US patent application (US 2006/0177847 A1, August 10, 2006), that they found the TOX polymorphism and other 27 DNA sequence variations to be related to OLZ-treatment-emergent weight gain and “metabolic syndrome” in a 1.7 million SNP genome association study.